Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Suyama H, Yamamoto N, Ushijima N

Open source

DOI
10.1002/ijc.23107
Published
2008 Jan 15
Container
International journal of cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.23107,
  title = {Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).},
  author = {Yamamoto N and Suyama H and Yamamoto N and Ushijima N},
  year = {2008},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.23107},
  url = {https://doi.org/10.1002/ijc.23107}
}

RIS

TY  - JOUR
TI  - Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).
AU  - Yamamoto N
AU  - Suyama H
AU  - Yamamoto N
AU  - Ushijima N
PY  - 2008
JO  - International journal of cancer
DO  - 10.1002/ijc.23107
UR  - https://doi.org/10.1002/ijc.23107
ER  - 

APA

N, Y., H, S., N, Y., & N, U. (2008). Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).. International journal of cancer. https://doi.org/10.1002/ijc.23107

Source records